BACKGROUND: Sleep disturbance remains a common symptom among cancer patients. Assessment of sleep disturbance in cancer patients is hindered by infrequent use of standardized tools for sleep management. OBJECTIVES: The purposes of this study were to validate the Taiwanese version of the Pittsburgh Sleep Quality Index (PSQI-T) and to determine detection cut-off points in cancer patients. DESIGN: A cross-sectional and descriptive correlational design. PARTICIPANTS: A sample of 205 Taiwanese patients with various cancer diagnoses. METHODS: The survey included the Pittsburgh Sleep Quality Index-Taiwanese version, the MD Anderson Symptom Inventory-Taiwanese version, the Brief Fatigue Inventory-Taiwanese version, the seven-day sleep log, and Manual of Mental Disorders, Fourth Edition. RESULTS: The internal consistency Cronbach's alpha for the PSQI was 0.79. Test-retest reliability was 0.91 for the global score over a 20- to 28-day interval in a sample of 16 patients. Construct validity was established by a significant relationship of the PSQI-T global score to the total symptom severity score and the fatigue severity score. Convergent validity was examined by correlating the PSQI-T scores and scores of the DSM-IV and scores on the seven-day sleep log. Known-group validity was established by comparing PSQI-T scores for patients having low fatigue levels and those having high fatigue levels. Receiver-operating characteristic (ROC) curves were used to determine the detection cut-off points. CONCLUSIONS: We found that a PSQI-T global score of 8 generates the best sensitivity and specificity for measuring sleep disturbance in cancer patients. The PSQI-T is a reliable, valid, and sensitive instrument for measuring sleep quality among Taiwanese cancer patients.
BACKGROUND:Sleep disturbance remains a common symptom among cancerpatients. Assessment of sleep disturbance in cancerpatients is hindered by infrequent use of standardized tools for sleep management. OBJECTIVES: The purposes of this study were to validate the Taiwanese version of the Pittsburgh Sleep Quality Index (PSQI-T) and to determine detection cut-off points in cancerpatients. DESIGN: A cross-sectional and descriptive correlational design. PARTICIPANTS: A sample of 205 Taiwanese patients with various cancer diagnoses. METHODS: The survey included the Pittsburgh Sleep Quality Index-Taiwanese version, the MD Anderson Symptom Inventory-Taiwanese version, the Brief Fatigue Inventory-Taiwanese version, the seven-day sleep log, and Manual of Mental Disorders, Fourth Edition. RESULTS: The internal consistency Cronbach's alpha for the PSQI was 0.79. Test-retest reliability was 0.91 for the global score over a 20- to 28-day interval in a sample of 16 patients. Construct validity was established by a significant relationship of the PSQI-T global score to the total symptom severity score and the fatigue severity score. Convergent validity was examined by correlating the PSQI-T scores and scores of the DSM-IV and scores on the seven-day sleep log. Known-group validity was established by comparing PSQI-T scores for patients having low fatigue levels and those having high fatigue levels. Receiver-operating characteristic (ROC) curves were used to determine the detection cut-off points. CONCLUSIONS: We found that a PSQI-T global score of 8 generates the best sensitivity and specificity for measuring sleep disturbance in cancerpatients. The PSQI-T is a reliable, valid, and sensitive instrument for measuring sleep quality among Taiwanese cancerpatients.
Authors: Jessica R Dietch; Daniel J Taylor; Kevin Sethi; Kimberly Kelly; Adam D Bramoweth; Brandy M Roane Journal: J Clin Sleep Med Date: 2016-08-15 Impact factor: 4.062
Authors: Fidel Hita-Contreras; Emilio Martínez-López; Pedro A Latorre-Román; Francisco Garrido; María A Santos; Antonio Martínez-Amat Journal: Rheumatol Int Date: 2014-02-08 Impact factor: 2.631
Authors: Michael R Irwin; Richard Olmstead; Carmen Carrillo; Nina Sadeghi; Perry Nicassio; Patricia A Ganz; Julienne E Bower Journal: J Clin Oncol Date: 2017-05-10 Impact factor: 44.544
Authors: Julie L Otte; Janet S Carpenter; Shalini Manchanda; Kevin L Rand; Todd C Skaar; Michael Weaver; Yelena Chernyak; Xin Zhong; Christele Igega; Carol Landis Journal: Cancer Med Date: 2014-11-30 Impact factor: 4.452
Authors: Anna Lipert; Remigiusz Kozłowski; Paweł Rasmus; Michał Marczak; Małgorzata Timler; Dariusz Timler; Ewa Kaniecka; Abedelmajid Nasser; Mohammad Ghaddar; Ali Ghaddar Journal: Int J Environ Res Public Health Date: 2021-06-27 Impact factor: 3.390